Description

This kit is used to quantitatively detect the nucleic acid content of human immunodeficiency virus Ⅰ (HIV- Ⅰ) in clinical
human serum and human plasma samples. It is used for auxiliary diagnosis of HIV-infection and monitoring of clinical effect
of anti-HIV-Ⅰdrug therapy.
The treatment evaluation of antiviral drugs is mainly based on two direct indicators: HIV-ⅠRNA titer in plasma and CD4+
cell count. In the tracking of antiviral drug treatment, this kit can quantitatively measure the titer of HIV-ⅠRNA in plasma,
dynamically reflect the change of HIV-ⅠRNA titer during treatment, and provide an index for efficacy evaluation.
Experimental operators should have received professional training in gene amplification or molecular biology method testing,
and have relevant experimental operating qualifications. The laboratory should have reasonable biological safety
precautions and protective procedures.
Test Principle
This kit based on real-time PCR fluorescence technology, the specific primers and corresponding fluorescent probes target
to HIV-Ⅰgenome were designed for highly specific detection. By detecting the fluorescent signals changes, the HIV-ⅠRNA
from serum or plasma specimen can be detected.